Phase I Clinical Trial of Vaxinia Oncolytic Virus; “the holy grail of cancer therapeutics”?
CF33-hNIS, a modified vaccinia (small pox) virus will be tested by IV or Intratumoral injection, with or without PD-1 inhibitor, pembrolizumab in patients with advanced or metastaic solid tumors.
